Active

Palmarium

Investor type

PE / Family office

Founded

2014

AUM

-

Location

Zürich, Zürich, Switzerland

Investment Ticket

$5-10 m

Investment Stage

Seed Series B

Region of investment

North America Europe
Investor profile last updated: 10 January, 2026

Profile

Palmarium is a private family office and investor with focus on alternative investments including private equity and real estate.

Industry

Healthcare Services IT Services Biotechnology Real Estate Medical Devices Pharmaceuticals MedTech Life Sciences Business Services (B2B) Financial Services Fintech HealthTech

Palmarium Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Palmarium Private Equity Investment Fund
Family office
Business Services (B2B)
Financial Services
Fintech
Real Estate
HealthTech
Seed
Series A
Series B
Europe
$5-10 m
—
July 2014

Contacts

Name
Title
Email
avatar
Graeme Oxby Head of TMT, Private Equity
Head of TMT, Private Equity
g•••@•••
avatar
Guido Van Berkel Chairman
Chairman
-
Upgrade to see contacts
avatar
SKeFJphwcsM3fx6b SKeFJphwcsM3fx6b
SKeFJphwcsM3fx6b
avatar
SKeFJphwcsM3fx6b SKeFJphwcsM3fx6b
SKeFJphwcsM3fx6b
avatar
SKeFJphwcsM3fx6b SKeFJphwcsM3fx6b
SKeFJphwcsM3fx6b
Investment-team contacts for Palmarium — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Palmarium

Palmarium is a private equity firm that also operates as a family office. It backs companies at Seed and Series B, writing tickets of $5-10 m.
Palmarium is located in Zürich, Zürich, Switzerland.
Palmarium was founded in 2014.
Palmarium invests in companies and startups in Healthcare Services, IT Services, Biotechnology, Real Estate, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Business Services (B2B), Financial Services, Fintech, HealthTech.
Palmarium invests in companies and startups in North America, Europe.
Palmarium invests in companies and startups at Seed, Series B.
Palmarium usually invests $5-10 m on average.
Palmarium last fund was created/launched in 2014-07-11
Palmarium can be reached through its website palmarium.ch and its LinkedIn page. Its general enquiries address is patrick.wild@palmarium.ch. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Palmarium — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Palmarium directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 10 January, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.